vimarsana.com

Latest Breaking News On - Nextcure daily - Page 3 : vimarsana.com

NextCure (NASDAQ:NXTC) Trading 0.9% Higher

NextCure, Inc. (NASDAQ:NXTC – Get Free Report)’s share price traded up 0.9% during trading on Monday . The company traded as high as $1.20 and last traded at $1.12. 124,661 shares traded hands during trading, an increase of 88% from the average session volume of 66,242 shares. The stock had previously closed at $1.11. Analyst […]

Needham-company
Nextcure-inc
Virtu-financial
Nasdaq
Tower-research-capital
Nextcure-company-profile
Cubist-systematic-strategies
Get-free-report
Street-group
Systematic-strategies
Research-capital

NextCure (NASDAQ:NXTC) Research Coverage Started at HC Wainwright

NextCure (NASDAQ:NXTC) Research Coverage Started at HC Wainwright
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Needham-company
Tower-research-capital
Jpmorgan-chase-co
Cubist-systematic-strategies
Nextcure-inc
Free-report
Moderate-buy
Systematic-strategies
Street-group
Research-capital
Get-free-report

NextCure (NASDAQ:NXTC) Coverage Initiated by Analysts at HC Wainwright

HC Wainwright initiated coverage on shares of NextCure (NASDAQ:NXTC – Free Report) in a report issued on Tuesday morning, MarketBeat reports. The brokerage issued a buy rating and a $7.00 price objective on the stock. Separately, Needham & Company LLC reaffirmed a buy rating and set a $6.00 price target on shares of NextCure in […]

Needham-company
Capital-management
Acadian-asset-management
Marquette-asset-management
Ieq-capital
Nextcure-inc
Free-report
Moderate-buy
Cure-stock-down
Asset-management
Get-free-report

NextCure (NASDAQ:NXTC) Earns "Buy" Rating from Needham & Company LLC

NextCure (NASDAQ:NXTC) Earns "Buy" Rating from Needham & Company LLC
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Renaissance-technologies
Cardiff-park-advisors
Capital-management
Dimensional-fund-advisors
Nextcure-inc
Needham-company
Get-free-report
Park-advisors
Fund-advisors
Nextcure-daily

Short Interest in NextCure, Inc. (NASDAQ:NXTC) Decreases By 17.9%

NextCure, Inc. (NASDAQ:NXTC – Get Free Report) was the recipient of a large decline in short interest during the month of July. As of July 15th, there was short interest totalling 221,600 shares, a decline of 17.9% from the June 30th total of 269,800 shares. Currently, 1.1% of the company’s shares are short sold. Based […]

Cubist-systematic-strategies
Virtu-financial
Tower-research-capital
Nextcure-inc
Nextcure-company-profile
Nasdaq
Get-free-report
Street-group
Systematic-strategies
Research-capital
Nextcure-daily

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.